[1]
“LEVOSIMENDAN AS BRIDGING THERAPY IN ADVANCED HEART FAILURE: CURRENT STATE OF KNOWLEDGE AND CLINICAL PERSPECTIVES”, IJITSS, vol. 4, no. 4(48), Dec. 2025, doi: 10.31435/ijitss.4(48).2025.4477.